Invitae Corporation (NYSE:NVTA) will hold its 3Q20 earnings conference call with the financial community on 5th November 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.invitae.com
Earnings Expectation
Invitae Corporation genetic information outfit, is expected to report third quarter earnings results, after market close, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.66 per share from revenue of $ 59.72 million. Looking ahead, the full year loss are expected at $ 3.24 per share on the revenues of $ 258.25 million.
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. Its tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; and screening and testing services in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company also operates AltaVoice, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories to deliver personalized genetic risk information.
